explore -WSS

explore

author：hotspot 2025-08-26 01:34:14 - browse：397

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Drug cartel violence flares in western Mexico after vigilante leader's killing

hotspot

WSS

Security flaws in third

Fatty liver disease was alleviated by Lilly’s ‘triple

What affirmative action's end means to a medical student

Security flaws in third

Ending health disparities requires full federal government, panel says

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Wikipedia

explore

hotspot

Virginia high school admissions case could be legal follow

Biden jokes that Republicans may impeach him because inflation is starting to cool down

George Santos makes 1st court appearance after pleading not guilty to 13 counts

As the dark side of IVF slowly comes into focus, even more transparency is needed

The cancer drug shortage isn’t new — and neither are the solutions

Interest rates are at a 22

The cancer drug shortage isn’t new — and neither are the solutions

What affirmative action's end means to a medical student

Heart attack and stroke risk calculators need revising

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

focus

An outrageous hospital charge: I paid $710 for an hour of babysitting

Hospitals, health systems can help patients avoid medical debt

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Biden jokes that Republicans may impeach him because inflation is starting to cool down

As the dark side of IVF slowly comes into focus, even more transparency is needed

CDC: Cases of alpha

hotspot

hotspot

hotspot

hotspot